Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver

被引:399
作者
Begriche, Karima [2 ]
Massart, Julie [1 ]
Robin, Marie-Anne [1 ]
Borgne-Sanchez, Annie [3 ]
Fromenty, Bernard [1 ]
机构
[1] INSERM, U991, F-35043 Rennes, France
[2] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA
[3] Hop Robert Debre, Mitol SAS, F-75019 Paris, France
关键词
Hepatotoxicity; Drugs; Mitochondria; Steatosis; Lipids; Cell death; Obesity; Oxidative stress; FATTY-ACID OXIDATION; PROLIFERATOR-ACTIVATED RECEPTOR; DNA-POLYMERASE-GAMMA; PREGNANE X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; MANGANESE SUPEROXIDE-DISMUTASE; TRIGLYCERIDE TRANSFER PROTEIN; HEPATIC CYTOCHROME-P450 2E1; STRESS-RELATED PARAMETERS; ELEMENT-BINDING PROTEINS;
D O I
10.1016/j.jhep.2010.11.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Numerous investigations have shown that mitochondrial dysfunction is a major mechanism of drug-induced liver injury, which involves the parent drug or a reactive metabolite generated through cytochromes P450. Depending of their nature and their severity, the mitochondrial alterations are able to induce mild to fulminant hepatic cytolysis and steatosis (lipid accumulation), which can have different clinical and pathological features. Microvesicular steatosis, a potentially severe liver lesion usually associated with liver failure and profound hypoglycemia, is due to a major inhibition of mitochondrial fatty acid oxidation (FAO). Macrovacuolar steatosis, a relatively benign liver lesion in the short term, can be induced not only by a moderate reduction of mitochondrial FAO but also by an increased hepatic de nova lipid synthesis and a decreased secretion of VLDL-associated triglycerides. Moreover, recent investigations suggest that some drugs could favor lipid deposition in the liver through primary alterations of white adipose tissue (WAT) homeostasis. if the treatment is not interrupted, steatosis can evolve toward steatohepatitis, which is characterized not only by lipid accumulation but also by necroinflammation and fibrosis. Although the mechanisms involved in this aggravation are not fully characterized, it appears that overproduction of reactive oxygen species by the damaged mitochondria could play a salient role. Numerous factors could favor drug-induced mitochondrial and metabolic toxicity, such as the structure of the parent molecule, genetic predispositions (in particular those involving mitochondrial enzymes), alcohol intoxication, hepatitis virus C infection, and obesity. In obese and diabetic patients, some drugs may induce acute liver injury more frequently while others may worsen the pre-existent steatosis (or steatohepatitis). (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:773 / 794
页数:22
相关论文
共 350 条
[21]   Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice [J].
Begriche, Karima ;
Letteron, Philippe ;
Abbey-Toby, Adje ;
Vadrot, Nathalie ;
Robin, Marie-Anne ;
Bado, Andre ;
Pessayre, Dominique ;
Fromenty, Bernard .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (05) :E939-E951
[22]   Effects of β-aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity [J].
Begriche, Karima ;
Massart, Julie ;
Fromenty, Bernard .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 (03) :269-282
[23]   Physiological aspects of the mitochondrial cyclosporin A-insensitive palmitate/Ca2+-induced pore: tissue specificity, age profile and dependence on the animal's adaptation to hypoxia [J].
Belosludtsev, Konstantin N. ;
Saris, Nils-Erik L. ;
Belosludtseva, Natalia V. ;
Trudovishnikov, Alexander S. ;
Lukyanova, Lyudmila D. ;
Mironova, Galina D. .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2009, 41 (04) :395-401
[24]   HALOTHANE BIOTRANSFORMATION IN OBESE AND NON-OBESE PATIENTS [J].
BENTLEY, JB ;
VAUGHAN, RW ;
GANDOLFI, AJ ;
CORK, RC .
ANESTHESIOLOGY, 1982, 57 (02) :94-97
[25]   The mitochondrial permeability transition from in vitro artifact to disease target [J].
Bernardi, P ;
Krauskopf, A ;
Basso, E ;
Petronilli, V ;
Blalchy-Dyson, E ;
Di Lisa, F ;
Forte, MA .
FEBS JOURNAL, 2006, 273 (10) :2077-2099
[26]   The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethane-sulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: Protection by albumin [J].
Berson, A ;
Cazanave, S ;
Descatoire, V ;
Tinel, M ;
Grodet, A ;
Wolf, C ;
Feldmann, G ;
Pessayre, D .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (01) :444-454
[27]   Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunction [J].
Berson, A ;
Renault, S ;
Letteron, P ;
Robin, MA ;
Fromenty, B ;
Fau, D ;
LeBot, MA ;
Riche, C ;
DurandSchneider, AM ;
Feldmann, G ;
Pessayre, D .
GASTROENTEROLOGY, 1996, 110 (06) :1878-1890
[28]  
Berson A, 2001, J PHARMACOL EXP THER, V299, P793
[29]   Mechanisms for experimental buprenorphine hepatotoxicity:: major role of mitochondrial dysfunction versus metabolic activation [J].
Berson, A ;
Fau, D ;
Fornacciari, R ;
Degove-Goddard, P ;
Sutton, A ;
Descatoire, V ;
Haouzi, D ;
Lettéron, P ;
Moreau, A ;
Feldmann, G ;
Pessayre, D .
JOURNAL OF HEPATOLOGY, 2001, 34 (02) :261-269
[30]  
BERSON A, 1994, J PHARMACOL EXP THER, V270, P167